Cellebrite DI Ltd. (NASDAQ:CLBT) Shares Purchased by True Wind Capital Management L.P.

True Wind Capital Management L.P. boosted its stake in Cellebrite DI Ltd. (NASDAQ:CLBT) by 18.2% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 13,861,007 shares of the company’s stock after buying an additional 2,130,386 shares during the period. Cellebrite DI accounts for approximately 87.1% of True Wind Capital Management L.P.’s holdings, making the stock its largest position. True Wind Capital Management L.P. owned 0.07% of Cellebrite DI worth $305,358,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. Pembroke Management LTD raised its position in shares of Cellebrite DI by 24.3% during the third quarter. Pembroke Management LTD now owns 1,908,345 shares of the company’s stock worth $32,137,000 after acquiring an additional 372,619 shares during the last quarter. Janney Montgomery Scott LLC increased its holdings in Cellebrite DI by 8.3% in the third quarter. Janney Montgomery Scott LLC now owns 51,155 shares of the company’s stock valued at $861,000 after purchasing an additional 3,912 shares during the last quarter. Harbor Capital Advisors Inc. grew its stake in Cellebrite DI by 96.1% in the third quarter. Harbor Capital Advisors Inc. now owns 95,351 shares of the company’s stock valued at $1,606,000 after acquiring an additional 46,727 shares during the period. Principal Financial Group Inc. acquired a new position in Cellebrite DI in the third quarter valued at about $23,402,000. Finally, Meritage Portfolio Management grew its stake in Cellebrite DI by 12.0% in the third quarter. Meritage Portfolio Management now owns 27,831 shares of the company’s stock valued at $469,000 after acquiring an additional 2,973 shares during the period. Institutional investors own 45.88% of the company’s stock.

Wall Street Analysts Forecast Growth

CLBT has been the subject of a number of research analyst reports. Craig Hallum boosted their target price on Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research note on Thursday, November 7th. Needham & Company LLC reaffirmed a “buy” rating and set a $28.00 price objective on shares of Cellebrite DI in a research report on Friday, February 14th. JPMorgan Chase & Co. upped their price objective on Cellebrite DI from $24.00 to $28.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 11th. Finally, Lake Street Capital upped their price objective on Cellebrite DI from $17.00 to $26.00 and gave the stock a “buy” rating in a research report on Friday, February 14th. Eight analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of $23.43.

Cellebrite DI Stock Performance

Shares of NASDAQ CLBT opened at $18.56 on Friday. The stock has a 50 day moving average price of $22.31 and a 200 day moving average price of $19.57. Cellebrite DI Ltd. has a 52 week low of $10.24 and a 52 week high of $26.30. The stock has a market capitalization of $3.82 billion, a PE ratio of -13.35, a price-to-earnings-growth ratio of 4.27 and a beta of 1.47.

Cellebrite DI (NASDAQ:CLBT) last released its quarterly earnings data on Thursday, February 13th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by ($0.03). Cellebrite DI had a negative net margin of 70.54% and a positive return on equity of 58.70%. As a group, research analysts forecast that Cellebrite DI Ltd. will post 0.3 EPS for the current year.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.